Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth: Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823)

Jiayan Lang; Xiao Zhao; Xiuchao Wang; Ying Zhao; Yiye Li; Ruifang Zhao; Keman Cheng; Yao Li; Xuexiang Han; Xiaowei Zheng; Hao Qin; Marzieh Geranpayehvaghei; Jian Shi; Gregory J. Anderson; Jihui Hao; He Ren; Guangjun Nie

doi:10.1021/acsnano.0c00042

Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth: Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823)

Jiayan Lang, Xiao Zhao, Xiuchao Wang, Ying Zhao, Yiye Li, Ruifang Zhao, Keman Cheng, Yao Li, Xuexiang Han, Xiaowei Zheng, Hao Qin, Marzieh Geranpayehvaghei, Jian Shi, Gregory J. Anderson, Jihui Hao, He Ren, Guangjun Nie

Houston Methodist

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

The authors regret that some incorrect images were inadvertently used when VEGF expression was shown in the TNP-DFO and TNP-DFO-YC1 groups of Figure 6E. This error occurred during the assembly of the figure. The correct images have now been incorporated. These corrections do not change the conclusions, the text of the article, or the figure legend. The authors apologize for any inconvenience caused to readers.

Original language	English (US)
Pages (from-to)	1211
Number of pages	1
Journal	ACS Nano
Volume	14
Issue number	1
DOIs	https://doi.org/10.1021/acsnano.0c00042
State	Published - Jan 28 2020

ASJC Scopus subject areas

General Materials Science
General Engineering
General Physics and Astronomy

Access to Document

10.1021/acsnano.0c00042

Fingerprint

Dive into the research topics of 'Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth: Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823)'. Together they form a unique fingerprint.

Cite this

Lang, J., Zhao, X., Wang, X., Zhao, Y., Li, Y., Zhao, R., Cheng, K., Li, Y., Han, X., Zheng, X., Qin, H., Geranpayehvaghei, M., Shi, J., Anderson, G. J., Hao, J., Ren, H., & Nie, G. (2020). Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth: Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823). ACS Nano, 14(1), 1211. https://doi.org/10.1021/acsnano.0c00042

Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth: Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823). / Lang, Jiayan; Zhao, Xiao; Wang, Xiuchao et al.
In: ACS Nano, Vol. 14, No. 1, 28.01.2020, p. 1211.

Research output: Contribution to journal › Comment/debate › peer-review

Lang, J, Zhao, X, Wang, X, Zhao, Y, Li, Y, Zhao, R, Cheng, K, Li, Y, Han, X, Zheng, X, Qin, H, Geranpayehvaghei, M, Shi, J, Anderson, GJ, Hao, J, Ren, H & Nie, G 2020, 'Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth: Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823)', ACS Nano, vol. 14, no. 1, pp. 1211. https://doi.org/10.1021/acsnano.0c00042

Lang J, Zhao X, Wang X, Zhao Y, Li Y, Zhao R et al. Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth: Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823). ACS Nano. 2020 Jan 28;14(1):1211. doi: 10.1021/acsnano.0c00042

Lang, Jiayan ; Zhao, Xiao ; Wang, Xiuchao et al. / Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth : Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823). In: ACS Nano. 2020 ; Vol. 14, No. 1. pp. 1211.

@article{cacf3d04bedf4d158ffee9453cc1c871,

title = "Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth: Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823)",

abstract = "The authors regret that some incorrect images were inadvertently used when VEGF expression was shown in the TNP-DFO and TNP-DFO-YC1 groups of Figure 6E. This error occurred during the assembly of the figure. The correct images have now been incorporated. These corrections do not change the conclusions, the text of the article, or the figure legend. The authors apologize for any inconvenience caused to readers.",

author = "Jiayan Lang and Xiao Zhao and Xiuchao Wang and Ying Zhao and Yiye Li and Ruifang Zhao and Keman Cheng and Yao Li and Xuexiang Han and Xiaowei Zheng and Hao Qin and Marzieh Geranpayehvaghei and Jian Shi and Anderson, \{Gregory J.\} and Jihui Hao and He Ren and Guangjun Nie",

year = "2020",

month = jan,

day = "28",

doi = "10.1021/acsnano.0c00042",

language = "English (US)",

volume = "14",

pages = "1211",

journal = "ACS Nano",

issn = "1936-0851",

publisher = "American Chemical Society",

number = "1",

}

TY - JOUR

T1 - Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth

T2 - Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth (ACS Nano (2019) 13:2 (2176−2189) DOI: 10.1021/acsnano.8b08823)

AU - Lang, Jiayan

AU - Zhao, Xiao

AU - Wang, Xiuchao

AU - Zhao, Ying

AU - Li, Yiye

AU - Zhao, Ruifang

AU - Cheng, Keman

AU - Li, Yao

AU - Han, Xuexiang

AU - Zheng, Xiaowei

AU - Qin, Hao

AU - Geranpayehvaghei, Marzieh

AU - Shi, Jian

AU - Anderson, Gregory J.

AU - Hao, Jihui

AU - Ren, He

AU - Nie, Guangjun

PY - 2020/1/28

Y1 - 2020/1/28

N2 - The authors regret that some incorrect images were inadvertently used when VEGF expression was shown in the TNP-DFO and TNP-DFO-YC1 groups of Figure 6E. This error occurred during the assembly of the figure. The correct images have now been incorporated. These corrections do not change the conclusions, the text of the article, or the figure legend. The authors apologize for any inconvenience caused to readers.

AB - The authors regret that some incorrect images were inadvertently used when VEGF expression was shown in the TNP-DFO and TNP-DFO-YC1 groups of Figure 6E. This error occurred during the assembly of the figure. The correct images have now been incorporated. These corrections do not change the conclusions, the text of the article, or the figure legend. The authors apologize for any inconvenience caused to readers.

UR - https://www.scopus.com/pages/publications/85078671091

UR - https://www.scopus.com/inward/citedby.url?scp=85078671091&partnerID=8YFLogxK

U2 - 10.1021/acsnano.0c00042

DO - 10.1021/acsnano.0c00042

M3 - Comment/debate

C2 - 31927949

AN - SCOPUS:85078671091

SN - 1936-0851

VL - 14

SP - 1211

JO - ACS Nano

JF - ACS Nano

IS - 1

ER -

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this